| 000 | 01458 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517212906.0 | ||
| 264 | 0 | _c20190718 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1469-8161 | ||
| 024 | 7 |
_a10.1017/S0031182018000677 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPanda, Chinmaya | |
| 245 | 0 | 0 |
_aIdentification of novel therapeutic candidates in Cryptosporidium parvum: an in silico approach. _h[electronic resource] |
| 260 |
_bParasitology _c12 2018 |
||
| 300 |
_a1907-1916 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntiprotozoal Agents _xpharmacology |
| 650 | 0 | 4 | _aComputational Biology |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 | _aCryptosporidiosis |
| 650 | 0 | 4 |
_aCryptosporidium parvum _xdrug effects |
| 650 | 0 | 4 | _aEpitopes, B-Lymphocyte |
| 650 | 0 | 4 | _aEpitopes, T-Lymphocyte |
| 650 | 0 | 4 | _aGenomics |
| 650 | 0 | 4 | _aHigh-Throughput Screening Assays |
| 650 | 0 | 4 | _aHistocompatibility Antigens Class I |
| 650 | 0 | 4 | _aHistocompatibility Antigens Class II |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMetabolic Networks and Pathways _xdrug effects |
| 650 | 0 | 4 | _aMolecular Conformation |
| 650 | 0 | 4 | _aMolecular Docking Simulation |
| 650 | 0 | 4 | _aProteome |
| 650 | 0 | 4 | _aProtozoan Vaccines |
| 700 | 1 | _aMahapatra, Rajani Kanta | |
| 773 | 0 |
_tParasitology _gvol. 145 _gno. 14 _gp. 1907-1916 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1017/S0031182018000677 _zAvailable from publisher's website |
| 999 |
_c28323585 _d28323585 |
||